GLP-1 Drugs: Slight Eye Risk, More Research Needed | JQJO

New studies reveal a potential link between GLP-1 agonist drugs like Ozempic and Wegovy and a slightly increased risk of NAION, a rare eye condition causing vision loss. One study showed a modest risk increase, while another found no increased risk of NAION but a slight rise in diabetic retinopathy. However, overall, GLP-1 users experienced fewer sight-threatening complications. Patients with pre-existing conditions like high blood pressure or diabetes should discuss risks with their doctor before starting these medications. Regular eye exams are crucial for early detection of complications.